Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Choosing your first blue chip crypto involves assessing liquidity, security, and use cases. This starter guide walks you through simple decision criteria.
25,502 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Analysts just boosted Crocs stock after recent upgrade rumors and data. This guide breaks down why the upgrade happen...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
ServiceNow stock falling today captures a moment of fear about AI disruption and rising expectations. This article br...
Eli Lilly stands at a pivotal moment for investors. With a massive market-cap and a growing GLP-1 portfolio, the ques...
Retirees face a tricky balance: can a mortgage under 6% really make buying a home worthwhile? This guide weighs the m...
AI is reshaping business, and a few durable names stand to benefit for years. Here are three artificial intelligence ...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Space investors are watching SpaceX's stock swing as it moves from early enthusiasm to a more tempered pullback. This...
When a stock pops today, investors want the real story behind the move. This guide breaks down what drove SLB stock t...
Meta just delivered a major update, but the stock still slid. This article explains what happened, why the move may b...